ERT Announces November Installments To Webinar Series

Educational Series Focuses on Suicide Risk Assessment, Centralized Risk-Based Monitoring and Cardiac Safety Testing in Clinical Trials

PHILADELPHIA– November 2, 2015 –– ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced the November 2015 installments to its Endpoints to Insights educational web seminar series. The series enables pharmaceutical researchers to participate in interactive programs in which ERT scientists and partner subject matter experts share their knowledge in optimizing the electronic collection of endpoint data and delivering real time business intelligence and analytics across clinical studies and programs.

The Endpoints to Insights series offers a convenient means for busy researchers and stakeholders to stay abreast of proven advances and current industry trends which will support their immediate and long-term development goals. The series’ November installments include:

- November 5, 2015: Effective Methods for Assessing Suicide Risk in Clinical Studies

- November 10, 2015: Optimal Approaches to Self-Service Analytics

- November 19, 2015: Are Thorough QT (TQT) Waivers Possible? New Approaches in Phase I Cardiac Safety

For additional information and to register for any upcoming webinars, please visit: https://www.ert.com/upcoming-webinars/. Access to recently recorded webinars can be found at https://www.ert.com/past-webinars/.

About ERT

ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.

ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.

Help employers find you! Check out all the jobs and post your resume.

Back to news